NL7714057A - O-gealkyleerde oximen, werkwijze voor het berei- den daarvan, alsmede werkwijze voor het bereiden van een geneesmiddel met hypolipidemische werking. - Google Patents

O-gealkyleerde oximen, werkwijze voor het berei- den daarvan, alsmede werkwijze voor het bereiden van een geneesmiddel met hypolipidemische werking.

Info

Publication number
NL7714057A
NL7714057A NL7714057A NL7714057A NL7714057A NL 7714057 A NL7714057 A NL 7714057A NL 7714057 A NL7714057 A NL 7714057A NL 7714057 A NL7714057 A NL 7714057A NL 7714057 A NL7714057 A NL 7714057A
Authority
NL
Netherlands
Prior art keywords
preparing
medicine
same
hypolipidemic action
oximes
Prior art date
Application number
NL7714057A
Other languages
English (en)
Dutch (nl)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NL7714057A publication Critical patent/NL7714057A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Epoxy Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL7714057A 1976-12-24 1977-12-19 O-gealkyleerde oximen, werkwijze voor het berei- den daarvan, alsmede werkwijze voor het bereiden van een geneesmiddel met hypolipidemische werking. NL7714057A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762658762 DE2658762A1 (de) 1976-12-24 1976-12-24 Neue o-alkylierte oxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
NL7714057A true NL7714057A (nl) 1978-06-27

Family

ID=5996577

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7714057A NL7714057A (nl) 1976-12-24 1977-12-19 O-gealkyleerde oximen, werkwijze voor het berei- den daarvan, alsmede werkwijze voor het bereiden van een geneesmiddel met hypolipidemische werking.

Country Status (18)

Country Link
US (1) US4358450A (es)
JP (2) JPS6044307B2 (es)
AT (1) AT359069B (es)
AU (1) AU514855B2 (es)
BE (1) BE862302A (es)
CA (1) CA1105019A (es)
CH (2) CH639654A5 (es)
DE (1) DE2658762A1 (es)
DK (1) DK146886C (es)
ES (3) ES465203A1 (es)
FI (1) FI773902A (es)
FR (1) FR2375224A1 (es)
GB (1) GB1542793A (es)
GR (1) GR71598B (es)
IT (1) IT1088927B (es)
NL (1) NL7714057A (es)
SE (1) SE433493B (es)
ZA (1) ZA777584B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2651083A1 (de) * 1976-11-09 1978-05-18 Hoechst Ag Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
US5214054A (en) * 1988-05-18 1993-05-25 Novo Nordisk A/S Azacyclic carboxylic acid derivatives and their preparation and use
US5229404A (en) * 1988-05-18 1993-07-20 Novo Nordisk A/S Azacyclic carboxylic acid derivatives and their preparation and use
JP2765876B2 (ja) * 1988-10-24 1998-06-18 科研製薬株式会社 ピリジルケトオキシムエーテル誘導体
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6089056A (en) * 1997-06-25 2000-07-18 Mitsui Kinzoku Kogyo Kabushiki Kaisha Structure for mounting a metallic pin into a resin part

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060177A (en) * 1957-11-11 1962-10-23 Ciba Geigy Corp O-(aminoalkyl)oxime derivatives of heterocyclic aldehydes and ketones
GB842968A (en) * 1957-11-11 1960-08-04 Ciba Ltd New o-aminoalkyl oximes
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes
GB1192995A (en) * 1967-04-12 1970-05-28 Egyt Gyogyszervegyeszeti Gyar Formimino Ethers
FR2187311B1 (es) * 1972-06-02 1975-06-20 Bouchara Emile
DE2235597A1 (de) * 1972-07-20 1974-01-31 Boehringer Mannheim Gmbh 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung
US4000274A (en) * 1972-12-23 1976-12-28 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing an n-aryl-n'-(phenyl-or-phenoxy-alkyl)-piperazine and method of use
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
US4083978A (en) * 1976-01-27 1978-04-11 Egyt Gyogyszervegyeszeti Gyar Oxime ethers

Also Published As

Publication number Publication date
FR2375224B1 (es) 1982-04-02
GR71598B (es) 1983-06-17
DK146886B (da) 1984-01-30
CA1105019A (en) 1981-07-14
ATA924577A (de) 1980-03-15
US4358450A (en) 1982-11-09
SE7714684L (sv) 1978-06-25
CH639654A5 (de) 1983-11-30
JPS5910661B2 (ja) 1984-03-10
JPS6044307B2 (ja) 1985-10-02
JPS54135774A (en) 1979-10-22
ZA777584B (en) 1978-11-29
AU514855B2 (en) 1981-03-05
AT359069B (de) 1980-10-27
FI773902A (fi) 1978-06-25
SE433493B (sv) 1984-05-28
ES468940A1 (es) 1978-12-16
ES465203A1 (es) 1978-09-16
AU3181477A (en) 1979-06-28
JPS53111076A (en) 1978-09-28
DK575077A (da) 1978-06-25
BE862302A (fr) 1978-06-23
DE2658762A1 (de) 1978-06-29
DK146886C (da) 1984-07-09
CH639649A5 (de) 1983-11-30
ES468939A1 (es) 1978-12-16
FR2375224A1 (fr) 1978-07-21
GB1542793A (en) 1979-03-28
IT1088927B (it) 1985-06-10

Similar Documents

Publication Publication Date Title
NL177704C (nl) Werkwijze voor het vervaardigen van een huls voor staafvormige rookwaar, de vervaardigde huls, en een rookstaaf met een vulmateriaal en deze huls.
NL7509077A (nl) Werkwijze voor het bereiden van een wasmiddel met sterke, fijnverdeeld vuilverwijderende werking.
NL190049C (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat met anti-inflammatoire werking.
NL169868C (nl) Werkwijze voor het op de orthoplaats(en) alkyleren van een fenol.
NL7712358A (nl) Werkwijze voor het vervaardigen van een zeef en de zeef op zichzelf.
NL971032I2 (nl) Werkwijze voor het bereiden van 2-cyclopropylamino-4,6-diamino-s-triazinen, werkwijze voor het bereiden van een preparaat voor het bestrijden van insekten.
NL171985C (nl) Werkwijze voor het bereiden van preparaten met werking tegen schistosomiasis, de aldus verkregen gevormde preparaten en werkwijze voor het bereiden van 1,2-dithioolverbindingen.
NL7712291A (nl) Gealkyleerde hydroxylaminen, werkwijze voor het bereiden ervan en werkwijze voor het bereiden van een geneesmiddel voor het behandelen van hypertonie.
NL7709391A (nl) Werkwijze voor het bereiden van verbindingen met hypolipidemische werking, alsmede farma- ceutische preparaten, die deze verbindingen bevatten.
NL7700702A (nl) 1,2-benzisothiazolinonen-3, werkwijze voor het bereiden ervan, alsmede de toepassing ervan als geneesmiddel.
NL7702369A (nl) 4-androsteen-3-onen en werkwijze voor het be- reiden daarvan, alsmede werkwijze voor het be- reiden van een geneesmiddel met diuretische werking.
NL7714057A (nl) O-gealkyleerde oximen, werkwijze voor het berei- den daarvan, alsmede werkwijze voor het bereiden van een geneesmiddel met hypolipidemische werking.
NL172245C (nl) Werkwijze voor het bereiden van een polyester en gevormde voortbrengselen, vervaardigd onder toepassing van de aldus bereide polyester.
NL7709488A (nl) Werkwijze voor het bereiden van een preparaat met insecticide en acaricide werking.
NL186315C (nl) Werkwijze voor het bereiden van een geneesmiddel met analgetische en antihyperthermische werking, gevormd geneesmiddel en werkwijze voor het bereiden van een geneeskrachtig p-aceetamidofenolderivaat.
NL181920C (nl) Werkwijze voor het bedrijven van althans een flessenreinigingsmachine, alsmede flessenreinigingsmachine.
NL179965C (nl) Werkwijze voor het bereiden van een preparaat met een fungicide werking.
NL7709007A (nl) Werkwijze voor het bereiden van nieuwe verbindingen met anti-bacteriele werking, alsmede gevormde far- maceutische preparaten die deze verbindingen bevat- ten.
NL7704218A (nl) Corticoiden, werkwijze voor het bereiden daar- van, alsmede werkwijze voor het bereiden van een geneesmiddel met anti-inflammatorische werking.
NL7503952A (nl) Holtecel, alsmede werkwijze voor het vervaardigen daarvan.
NL7713595A (nl) Corticoiden, werkwijze voor het bereiden daar- van alsmede werkwijze voor het bereiden van een geneesmiddel met anti-flogistische werking.
NL7713663A (nl) Werkwijze voor de bereiding van een persmateriaal, en voorwerpen vervaardigd onder toepassing van het aldus bereide persmateriaal.
NL7805114A (nl) 17 -hydroxy-4-androsteen-3-onen, werkwijze voor het be- reiden daarvan, alsmede werkwijze voor het bereiden van een geneesmiddel met diuretische werking op basis van deze verbindingen.
NL7610834A (nl) Werkwijze voor het bereiden van 1,3-benzodithio- feen-2-on en 1,3-benzodithiofeen-2-thionverbin- dingen met biocide activiteit.
NL7714054A (nl) Basisch gesubstitueerde o-propyloximen, werkwij- ze voor het bereiden daarvan en werkwijze voor het bereiden van een geneesmiddel met bloeddruk- verlagende werking.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed